相关实验视频
Updated: May 15, 2025

10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
3.0K
管理与 patent foramen ovale 相关的密码性中风中的抗凝血和血栓栓塞风险
Gautier Randour1, Nicolas Brassart2, Marie Dagonnier3
1Physical and Rehabilitation Medicine, HELORA Réseau Hospitalier, Mons, Walloon Region, Belgium.
BMJ case reports
|April 7, 2025
概括
年轻成年人的密码性中风可能与形孔 (PFO) 有关. 这个案例显示了PFO患者中风,深静脉血栓和出血风险的复杂管理.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 血管医学 血管医学
背景情况:
- 年轻成年人的密码性中风 (CS) 是一个重大的临床挑战.
- 形孔 (PFO) 是 CS. 的潜在潜在原因.
- 在这些患者中,控制血栓栓塞和出血风险需要仔细考虑.
研究的目的:
- 在一个年轻的成年人身上呈现一个复杂的密码性中风病例,具有大型的 patent foramen ovale.
- 为了说明诊断和治疗的挑战,在管理相关的条件,如深静脉血栓和大流动.
- 强调在这种情况下需要个性化,多学科的方法.
主要方法:
- 病例报告详细介绍患者的介绍,诊断工作和治疗过程.
- 利用神经成像来确认缺血性中风和动脉堵塞.
- 研究血栓栓塞现象,包括PFO,心房隔膜动脉瘤和深静脉血栓症.
主要成果:
- 大型PFO与心房隔膜动脉瘤被确定为可能导致缺血性中风的因素.
- 患者经历了严重的中流动,需要安装下腔静脉 (IVC) 过器.
- 尽管进行了干预,但发生了广泛的IVC血栓形成,需要抗凝管理.
结论:
- 这一案例强调了与PFO相关的密码性中风管理的复杂性.
- 彻底的病因评估至关重要,以区分致病性和偶然的PFO.
- 个性化,多学科的策略是必要的,以有效地平衡血栓栓塞和出血风险.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
568
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
568
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
417
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
417
Clot Retraction and Fibrinolysis
3.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.0K
Disorders of Hemostasis
658
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
658

